Despite intense research on autoimmune diseases like lupus, little is still known on how the immune system works to attack…
Articles by Ines Martins, PhD
The Lupus Foundation of America has invited Scottsdale, Arizona’s Mayor, Jim Lane, as its guest of honor during the annual Walk…
NEOVACS, a leading biotechnology company focused on an active immunotherapy technology platform (Kinoids) with applications in autoimmune and/or inflammatory diseases,…
Pregnant women with lupus (a rheumatic autoimmune condition) have an increased risk of transmitting the condition to their newborns, especially if they have…
XTL Biopharmaceuticals Ltd., a biopharmaceutical company focused on the acquisition, development, and commercialization of pharmaceutical products for the treatment…
Results from a study recently published in the journal Arthritis Care and Research showed that the lower…
While biomedical research and development has come a long way in understanding lupus and how to manage it, experts believe…
Australian pharmaceutical giant Invion Limited, recently completed its phase II clinical study on INV103 (ala-Cpn10) in patients with systemic lupus…
Results from a Phase 2a clinical trial  recently presented during the European League Against Rheumatism Annual European Congress of Rheumatology…
Results from a phase 2 clinical trial recently published in the journal Lupus Science and Medicine revealed…